 |
This Is MS Multiple Sclerosis Community: Knowledge & SupportWelcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones. |
| It is currently Sun May 26, 2013 2:20 am |
|
All times are UTC - 8 hours [ DST ] |
 
|
Page 1 of 1 |
[ 1 post ] |
|
| Author | Message | |||||
|---|---|---|---|---|---|---|
| squiffy2 |
|
|||||
Joined: Wed Oct 14, 2009 3:00 pm Posts: 1689 |
|
|||||
| Top |  |
|||||
 |
||||||
|
|
Page 1 of 1 |
[ 1 post ] |
|
All times are UTC - 8 hours [ DST ] |
| Topics | Author | Replies | Views | Last post | |
|---|---|---|---|---|---|
 | Daclizumab (Zenapax) shows promise in MS | 0 | 530 | Mon Oct 24, 2011 2:13 am | |
| Monoclonal antibody daclizumab (Zenapax) cuts MRI lesions | 3 | 617 | Sat Nov 26, 2011 9:07 am | |
| mri lesions and disease activity -- your experience? | 8 | 1177 | Mon May 09, 2011 2:14 pm | |
| Disease-activity-free status in patients with cladribine | 0 | 707 | Wed Mar 16, 2011 1:07 am | |
| Zenapax | 0 | 1256 | Fri Feb 25, 2005 11:41 am | |
Who is online |
Users browsing this forum: No registered users |
| You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum |
News 
Site map 
SitemapIndex 
RSS Feed Channel list
Login
Register
FAQ
Search
